Paper41269477
Metformin alleviates presbycusis by activating the SIRT1/PINK1/GPX4 pathway in vitro and in vivo.
Zeng C and 7 others. Inflammopharmacology, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Metformin alleviates presbycusis by activating the SIRT1/PINK1/GPX4 pathway in vitro and in vivo. Papers, record 41269477. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41269477
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Metformin alleviates presbycusis by activating the SIRT1/PINK1/GPX4 pathway in vitro and in vivo.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirtuin 1 | Major topic |
| Metformin | Major topic |
| Presbycusis | Major topic |
| Protein Kinases | Major topic |
| Phospholipid Hydroperoxide Glutathione Peroxidase | Major topic |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Signal Transduction | |
| Evoked Potentials, Auditory, Brain Stem | |
| Reactive Oxygen Species | |
| Mitochondria | |
| Male | |
| Cell Line | |
| Cell Survival | |
| Galactose | |
| Humans | |
| Hair Cells, Auditory | |
| Disease Models, Animal |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024109 | Medical Research Foundation of Putian University | PubMed | ||
| 2025J011523 | Natural Science Foundation of Fujian Province | PubMed | ||
| 2023GGA035 | Fujian Provincial Healthcare Young and Middle-aged Backbone Talent Training Project | PubMed | ||
| 2023Y9019 | Joint Funds for the Innovation of Science and Technology | PubMed | ||
| 2021Y9099 | Science and Technology Innovation Joint Funding Project of Fujian Province | PubMed |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31947524 | Presbycusis: An Update on Cochlear Mechanisms and Therapies. | J Clin Med | 2020 | https://conductscience.org/library/papers/31947524 | PubMed |
| 2 | 38301497 | Impact of fermented feed of soybean hulls and rapeseed cake on immunity, antioxidant capacity, and gut microbiota in Chahua chicken. | Poult Sci | 2024 | https://conductscience.org/library/papers/38301497 | PubMed |
| 3 | 37272058 | GPX4 in cell death, autophagy, and disease. | Autophagy | 2023 | https://conductscience.org/library/papers/37272058 | PubMed |
| 4 | 32387126 | Reduced mitophagy in the cochlea of aged C57BL/6J mice. | Exp Gerontol | 2020 | https://conductscience.org/library/papers/32387126 | PubMed |
| 5 | 38414247 | Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice. | Mol Ther | 2024 | https://conductscience.org/library/papers/38414247 | PubMed |
| 6 | 33625942 | Metformin alleviates cisplatin-induced ototoxicity by autophagy induction possibly via the AMPK/FOXO3a pathway. | J Neurophysiol | 2021 | https://conductscience.org/library/papers/33625942 | PubMed |
| 7 | 30693443 | ROS-Induced Activation of DNA Damage Responses Drives Senescence-Like State in Postmitotic Cochlear Cells: Implication for Hearing Preservation. | Mol Neurobiol | 2019 | https://conductscience.org/library/papers/30693443 | PubMed |
| 8 | 38200521 | ErZhiTianGui Decoction alleviates age-related ovarian aging by regulating mitochondrial homeostasis and inhibiting ferroptosis. | J Ovarian Res | 2024 | https://conductscience.org/library/papers/38200521 | PubMed |
| 9 | 30459716 | Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation. | Front Endocrinol (Lausanne) | 2018 | https://conductscience.org/library/papers/30459716 | PubMed |
| 10 | 39584158 | Beyond the cochlea: exploring the multifaceted nature of hearing loss in primary mitochondrial diseases. | Brain Commun | 2024 | https://conductscience.org/library/papers/39584158 | PubMed |
| 11 | 37001616 | GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment. | Biochim Biophys Acta Rev Cancer | 2023 | https://conductscience.org/library/papers/37001616 | PubMed |
| 12 | 33953438 | The world report on hearing, 2021. | Bull World Health Organ | 2021 | https://conductscience.org/library/papers/33953438 | PubMed |
| 13 | 38307325 | Intermittent fasting protects β-cell identity and function in a type-2 diabetes model. | Metabolism | 2024 | https://conductscience.org/library/papers/38307325 | PubMed |
| 14 | 39690329 | Metformin lowers risk of hearing loss and mortality in type 2 diabetes. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/39690329 | PubMed |
| 15 | 34408646 | Auditory Threshold Variability in the SAMP8 Mouse Model of Age-Related Hearing Loss: Functional Loss and Phenotypic Change Precede Outer Hair Cell Loss. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34408646 | PubMed |
| 16 | 32333835 | Benefits of Metformin in Attenuating the Hallmarks of Aging. | Cell Metab | 2020 | https://conductscience.org/library/papers/32333835 | PubMed |
| 17 | 38255232 | Anti-Aging Drugs and the Related Signal Pathways. | Biomedicines | 2024 | https://conductscience.org/library/papers/38255232 | PubMed |
| 18 | 40356329 | DLK/JNK3 Upregulation Aggravates Hair Cell Senescence in Mice Cochleae via Excessive Autophagy. | Aging Cell | 2025 | https://conductscience.org/library/papers/40356329 | PubMed |
| 19 | 32169097 | PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease. | Mol Neurodegener | 2020 | https://conductscience.org/library/papers/32169097 | PubMed |
| 20 | 38012584 | Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signaling pathway. | BMC Cardiovasc Disord | 2023 | https://conductscience.org/library/papers/38012584 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42814283 | Therapeutic Timing at Mitochondrial Redox-Autophagy-Mitophagy Checkpoints in Age-Related Hearing Loss. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42814283 | PubMed |
| 42168415 | Role of YAP/TAZ Mechanobiological Signaling in Osteoporosis and Osteoarthritis. | Calcif Tissue Int | 2026 | https://conductscience.org/library/papers/42168415 | PubMed |
| 41618858 | Gut-Metabolome-Proteome Interactions in Age-Related Hearing Loss: Insights from Fecal Microbiota Transplantation and Multi-Omics Analyses. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41618858 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41269477
GET https://conductscience.org/api/papers/v1/41269477/references?page=2